首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
【2h】

Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.

机译:用5-HT1激动剂(8-OH-DPAT和RU 24969)和拮抗剂(异黄酮)进行长期治疗对小鼠对5-HT1和5-HT2激动剂的行为反应的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effects of chronic (14 day) administration to mice of the 5-HT1 agonists 8-hydroxy 2-(di-n-propylamino) tetralin (8-OH-DPAT) and 5-methoxy-3 (1,2,3,6-tetrahydropyridin-4-yl) IH indole (RU 24969) on the hypothermic response to 8-OH-DPAT and the locomotor response to RU 24969 have been examined. Chronic administration of 8-OH-DPAT (5 mg kg-1, s.c.) resulted in an attenuated hypothermic response to this drug given subcutaneously (s.c.) or intracerebroventricularly (i.c.v.) but did not alter the locomotor response to RU 24969. Chronic injection of RU 24969 (3 mg kg-1, i.p.) produced an attenuated locomotor response to this drug given i.p. or i.c.v. but not the hypothermic response to 8-OH-DPAT (0.5 mg kg-1, s.c.). Chronic administration of the putative presynaptic 5-HT1 antagonist isapirone (10 mg kg-1, i.p.) decreased the hypothermic response following 8-OH-DPAT injection but did not alter RU 24969-induced locomotion. Chronic treatment with 8-OH-DPAT (5 mg kg-1, s.c.) produced a modest enhancement of the 5-HT2 receptor-mediated head-twitch behaviour initiated by 5-hydroxytryptophan injection while chronic isapirone decreased this behavioural response. 5-HT2 receptor number in frontal cortex was unaltered by isapirone treatment but markedly decreased (34%) by chronic 8-OH-DPAT. These data suggest that chronic administration of the 5-HT1 agonists induces tolerance in their respective responses but not cross-tolerance, while chronic isapirone may down-regulate the 5-HT1A site in a matter analogous to that seen by 5-HT2 receptors following 5-HT2 receptor antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:长期(14天)对5-HT1激动剂8-羟基2-(二-正丙基氨基)四氢化萘(8-OH-DPAT)和5-甲氧基-3(1,2,3,已经研究了6-四氢吡啶-4-基)IH吲哚(RU 24969)对8-OH-DPAT的低温反应和对RU 24969的运动反应。长期服用8-OH-DPAT(5 mg kg-1,sc)导致对该药物的皮下注射(sc)或脑室内注射(icv)的低温反应减弱,但并未改变对RU 24969的运动反应。 RU 24969(3 mg kg-1,ip)对这种药物给予ip产生减弱的运动反应或i.c.v.但对8-OH-DPAT(0.5 mg kg-1,s.c.)的低温反应却没有。长期给予推定的突触前5-HT1拮抗剂异黄酮(10 mg kg-1,腹膜内)降低了注射8-OH-DPAT后的低温反应,但未改变RU 24969诱导的运动。用8-OH-DPAT(5 mg kg-1,s.c.)进行慢性治疗可适度增强5-羟色氨酸注射引发的5-HT2受体介导的头抽搐行为,而慢性异黄酮可降低这种行为反应。异黄酮的治疗不会改变额叶皮层中的5-HT2受体数量,但通过慢性8-OH-DPAT可以显着降低(34%)。这些数据表明,长期服用5-HT1激动剂可诱导其各自反应的耐受性,但不会交叉耐受,而慢性异黄酮可能下调5-HT1A部位,类似于5-HT2受体在5次后所见。 -HT2受体拮抗剂(摘要截短为250个字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号